Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa

Neurology. 2003 Sep 23;61(6 Suppl 3):S43-8. doi: 10.1212/wnl.61.6_suppl_3.s43.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Biomarkers / analysis
  • Clinical Trials as Topic / statistics & numerical data
  • Diagnostic Imaging
  • Disease Progression
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Humans
  • Levodopa / adverse effects
  • Levodopa / therapeutic use*
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy*
  • Radionuclide Imaging
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Biomarkers
  • Dopamine Agonists
  • Levodopa